Turnstone Biologics Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Turnstone Biologics Corp. |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials, agreements
TL;DR
Turnstone Biologics Q1 2025 10-Q filed. Myst Merger & Moffitt Cancer Center deal details out.
AI Summary
Turnstone Biologics Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates. Key events mentioned include the Myst Merger Agreement and an Alliance Agreement with H. Lee Moffitt Cancer Center, alongside details on compensation and equity incentive plans.
Why It Matters
This filing provides investors with a quarterly update on Turnstone Biologics' financial health and strategic developments, including significant agreements and compensation structures.
Risk Assessment
Risk Level: medium — The company operates in the highly competitive and regulated biotechnology sector, facing risks related to drug development, clinical trials, and market adoption.
Key Players & Entities
- Turnstone Biologics Corp. (company) — Filer of the 10-Q
- H. Lee Moffitt Cancer Center (company) — Party to an Alliance Agreement
- Myst Merger Agreement (company) — Significant agreement mentioned
- 20250331 (date) — End of the reporting period
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001764974.
What is the business address of Turnstone Biologics Corp.?
The business address is 9310 Athena Circle, Suite 300, La Jolla, CA 92037.
What is the SIC code for Turnstone Biologics Corp.?
The Standard Industrial Classification (SIC) code is 2836 for Biological Products (No Diagnostic Substances).
What significant agreements are mentioned in the filing?
The filing mentions the Myst Merger Agreement and an Alliance Agreement with H. Lee Moffitt Cancer Center.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding Turnstone Biologics Corp..